Значения термина carcinomatous meningitis на английском

The median survival after diagnosis of carcinomatous meningitis was 77 days.

Approximately 50% of patients with carcinomatous meningitis die from other causes, including systemic disease.

Therefore, large studies to assess the value of CSF tumor marker changes in carcinomatous meningitis are warranted.

Given our findings, CSF tumor marker evaluation may provide a reliable means and surrogate end-points of monitoring response of carcinomatous meningitis to treatment.

Conclusions: Given our findings, CSF tumor marker evaluation may provide a reliable means and surrogate end-points of monitoring response of carcinomatous meningitis to treatment.

Carcinomatous meningitis (CM) is an uncommon but devastating complication of malignancy.

Conclusions: Carcinomatous meningitis from breast carcinoma is an aggressive metastatic complication with a poor prognosis.

Background: Carcinomatous meningitis is a rare and often devastating complication in patients with breast cancer, and the treatment is controversial.